BIOPHARMA CONSULTING | COMPETITIVE POSITIONING
About
Cade Group
Cade Group was founded in 2024 out of a demand from early-stage biotech companies for support with positioning their CNS assets in a highly competitive landscape. At every stage of development, the window closes on the ability to differentiate in the market. Cade Group’s guiding belief is that commercial success depends on competitive positioning as early as possible in an asset’s life cycle.
What We Deliver
Indication Prioritization Analyses
A comprehensive analysis that combines an in-depth briefing book with a succinct indication scoring assignment to determine all relevant qualitative and quantitative aspects for a given asset.
Target Product Profiles
A detailed overview of the relevant characteristics of the target profile, including patient population, efficacy endpoints, and safety profile that roles up into a one-pager to guide asset development.
Medical Value Propositions
A necessary statement to support pharmaceutical positioning: what you want to say in the future to be competitive and to maximize commercial success, not what you think can be said about an asset today.
Clinical Development Plans
Identifying key studies and outlining timelines to commercial launch as well as providing study design considerations for product differentiation starting from Phase 1.
Voice of Customer
Connecting with the Three P’s (Patients, Providers, and Payers) by developing a list of KOLs, building scientific adboards, conducting confidential Three P interviews, and incorporating all feedback into an integrated asset development plan.
Venture Financing
Securing nontraditional financing opportunities for clinical or near clinical stage companies
Fractional Team Solutions
Our team of seasoned professionals offers strategic insights and tailored solutions to elevate your business. Trust our expertise to guide your organization towards achieving its goals.